Creative Planning’s Cidara Therapeutics CDTX Stock Holding History

Creative Planning’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,921	Closed	-$424K	–	4113
2025 Q4	$424K	Buy	+1,921	New	+$310K	﹤0.01%	2975

Creative Planning's CDTX Position: Q1 2026 in Review

Creative Planning sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,921 shares — an estimated $424K sold.

Creative Planning first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $424K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Creative Planning reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Creative Planning sold 1,921 Cidara Therapeutics shares in Q1 2026, an estimated $424K.
Creative Planning first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Creative Planning's Cidara Therapeutics position peaked at $424K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.